magnifying glass
logo for Kaleido

Kaleido

Get Full Access

Description

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the microbiome organ to treat disease ... Read More

Headquarters

Headquarters:

65 Hayden Ave, Lexington, Massachusetts, 02421, United States
Phone

Phone:

(617) 674-9000
Employees

Employees:

118
Revenue

Revenue:

$24 Million
Stock Symbol

Stock Symbol:

KLDO
Kaleido's Social Media
SIC Code 87,873
NAICS Code 622310,6221
Ticker NASDAQ: KLDO
Popular Searches:

Kaleido Biosciences, Inc.

Kaleido BioSciences , Inc.

Kaleido Biosciences

Kaleido Biosciences Inc

Kaleidoscope

Top Competitors of Kaleido

Employess
98
revenue
$20 Million

1

Employess
83
revenue
$5 Million

2

Employess
50
revenue
<$5 Million

3

Employess
67
revenue
$13 Million

4

Employess
60
revenue
<$5 Million

5

Employess
81
revenue
$16 Million

6

Kaleido's Org Chart

Daniel Menichella
Daniel Menichella

President & Chief Executive Officer

PhonePhoneEmailEmail
William Duke
William Duke

Chief Financial Officer

PhonePhoneEmailEmail
Jerald Korn
Jerald Korn

General Counsel, Corporate Secreta...

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Kaleido Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateRoundAmountInvestors

Mar 04, 2019

Stock Issuance/Offering

$75M

Undisclosed

Jun 25, 2018

Series C

$101M

Fidelity Management and Research Company

Sep 18, 2017

Series B

$65M

Flagship Pioneering

See More

$245M

Total Funding Amount

$75M

Most Recent Funding Amount

4

Number of Funding Rounds

Revenue
QuarterRevenue

'20 - Q3

24938000

'20 - Q4

24938000

'21 - Q1

24938000

'21 - Q2

24938000

Kaleido's Tech Stack

Google Global Site Tag

By

Google

Freshservice

By

Freshworks

Office 365

By

Microsoft

WordPress.org

By

Automattic

Drupal

By

Drupal

Google Font API

By

Google
See more technologies

Kaleido News & Media

Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions

LEXINGTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, small-molecule approach to treating inflammatory conditions and diseases by selectively targeting the resident microbiome to restore gut-immune homeostasis, today announced the extension and expansion of its research collaboration with Janssen Biotech, Inc. (“Janssen”). The collaboration is designed to explore the potential for Microbiome Metabolic

Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

LEXINGTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, small-molecule approach to treating inflammatory conditions and diseases by selectively targeting the resident microbiome to restore gut-immune homeostasis, today announced that CEO Dan Menichella will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference. The presentation will be available on-demand starting

Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer

LEXINGTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, small-molecule approach to treating inflammatory conditions and diseases by selectively targeting the resident microbiome to restore gut-immune homeostasis, today announced the appointment of Alison Long, M.B.B.Ch., Ph.D., to its leadership team as Chief Medical Officer, effective December 15, 2021. In her new role, Dr. Long will be responsible for
Subscribe to "Kaleido" News

Frequently Asked Questions regarding Kaleido

Where are Kaleido’s headquarters?

Kaleido’s headquarters are in 65 Hayden Ave, Lexington, Massachusetts, 02421, United States

What is Kaleido’s phone number?

Kaleido’s phone number is (617) 674-9000

What is Kaleido’s stock symbol?

Kaleido’s stock symbol is KLDO

What is Kaleido’s official website?

Kaleido’s official website is //www.kaleido.com

What is Kaleido’s Revenue?

Kaleido’s revenue is $24 Million

What is Kaleido’s SIC code?

Kaleido’s SIC: 87,873

What is Kaleido’s NAICS code?

Kaleido’s NAICS: 622310,6221

How many employees are working in Kaleido?

Kaleido has 118 employees

What is Kaleido’s industry?

Kaleido is in the industry of: Business Services General, Business Services, Emergency Medical Transportation & Services

Who are Kaleido’s main competitors?

Kaleido's main competitors are: Evelo Biosciences, Athersys, GlycoMimetics, CellCentric

What is Kaleido's tech stack?

The technologies that are used by Kaleido are: Google Global Site Tag, Freshservice, Office 365, WordPress.org

Who is Kaleido's CEO?

Kaleido's CEO is Steve Cerveny

Who is Kaleido's CFO?

Kaleido's CFO is William Duke

See more information about Kaleido

Browse ZoomInfo’s Directories